Modeling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practice

Miguel A Ruiz,1 Enrique Álvarez,2 Jose L Carrasco,3 José M Olivares,4 María Pérez,5 Javier Rejas6 1Department of Methodology, School of Psychology, Universidad Autónoma de Madrid, Madrid, 2Department of Psychiatry, Hospital de la Santa Creu i S...

Full description

Bibliographic Details
Main Authors: Ruiz MA, Álvarez E, Carrasco JL, Olivares JM, Pérez M, Rejas J
Format: Article
Language:English
Published: Dove Medical Press 2015-08-01
Series:Drug Design, Development and Therapy
Online Access:http://www.dovepress.com/modeling-the-longitudinal-latent-effect-of-pregabalin-on-self-reported-peer-reviewed-article-DDDT
_version_ 1819016977718444032
author Ruiz MA
Álvarez E
Carrasco JL
Olivares JM
Pérez M
Rejas J
author_facet Ruiz MA
Álvarez E
Carrasco JL
Olivares JM
Pérez M
Rejas J
author_sort Ruiz MA
collection DOAJ
description Miguel A Ruiz,1 Enrique Álvarez,2 Jose L Carrasco,3 José M Olivares,4 María Pérez,5 Javier Rejas6 1Department of Methodology, School of Psychology, Universidad Autónoma de Madrid, Madrid, 2Department of Psychiatry, Hospital de la Santa Creu i San Pau, Barcelona, 3Department of Psychiatry, Hospital Clínico San Carlos, Madrid, 4Department of Psychiatry, Hospital Meixoeiro, Complejo Hospitalario Universitario, Vigo, 5Medical Department, Pfizer, S.L.U., Alcobendas, Madrid, 6Health Economics and Outcomes Research Department, Pfizer, S.L.U., Alcobendas, Madrid, Spain Background: Anxiety disorders are among the most common psychiatric illnesses, with generalized anxiety disorder (GAD) being one of the most common. Sleep disturbances are highly prevalent in GAD patients. While treatment with pregabalin has been found to be associated with significant improvement in GAD-related sleep disturbance across many controlled clinical trials, mediational analysis has suggested that a substantial portion of this effect could be the result of a direct effect of pregabalin. Thus, the objective of this study was to model the longitudinal latent effect of pregabalin or usual care (UC) therapies on changes in sleep in outpatients with GAD under routine clinical practice. Methods: Male and female GAD outpatients, aged 18 years or above, from a 6-month prospective noninterventional trial were analyzed. Direct and indirect effects of either pregabalin or UC changes in anxiety symptoms (assessed with Hamilton Anxiety Scale) and sleep disturbances (assessed with Medical Outcomes Study-Sleep Scale [MOS-S]) were estimated by a conditional latent curve model applying structural equation modeling. Results: A total of 1,546 pregabalin-naïve patients were analyzed, 984 receiving pregabalin and 562 UC. Both symptoms of anxiety and sleep disturbances were significantly improved in both groups, with higher mean (95% confidence interval) score reductions in subjects receiving pregabalin: -15.9 (-15.2; -16.6) vs -14.5 (-13.5; -15.5), P=0.027, in Hamilton Anxiety Scale; and -29.7 (-28.1; -31.3) vs -24.0 (-21.6; -26.4), P<0.001, in MOS-S. The conditional latent curve model showed that the pregabalin effect on sleep disturbances was significant (γ =-3.99, P<0.001), after discounting the effect on reduction in anxiety symptoms. A mediation model showed that 70% of the direct effect of pregabalin on sleep remained after discounting the mediated effect of anxiety improvement. Conclusion: A substantial proportion of the incremental improvements in anxiety-related sleep disturbances with pregabalin vs UC were explained by its direct effect, not mediated by improvements in anxiety symptoms. Keywords: latent curve analysis, pregabalin, usual care, generalized anxiety disorders, sleep disturbances
first_indexed 2024-12-21T02:56:12Z
format Article
id doaj.art-2ecedea5250641cd8bdf654413040a39
institution Directory Open Access Journal
issn 1177-8881
language English
last_indexed 2024-12-21T02:56:12Z
publishDate 2015-08-01
publisher Dove Medical Press
record_format Article
series Drug Design, Development and Therapy
spelling doaj.art-2ecedea5250641cd8bdf654413040a392022-12-21T19:18:19ZengDove Medical PressDrug Design, Development and Therapy1177-88812015-08-012015default4329434023006Modeling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practiceRuiz MAÁlvarez ECarrasco JLOlivares JMPérez MRejas JMiguel A Ruiz,1 Enrique Álvarez,2 Jose L Carrasco,3 José M Olivares,4 María Pérez,5 Javier Rejas6 1Department of Methodology, School of Psychology, Universidad Autónoma de Madrid, Madrid, 2Department of Psychiatry, Hospital de la Santa Creu i San Pau, Barcelona, 3Department of Psychiatry, Hospital Clínico San Carlos, Madrid, 4Department of Psychiatry, Hospital Meixoeiro, Complejo Hospitalario Universitario, Vigo, 5Medical Department, Pfizer, S.L.U., Alcobendas, Madrid, 6Health Economics and Outcomes Research Department, Pfizer, S.L.U., Alcobendas, Madrid, Spain Background: Anxiety disorders are among the most common psychiatric illnesses, with generalized anxiety disorder (GAD) being one of the most common. Sleep disturbances are highly prevalent in GAD patients. While treatment with pregabalin has been found to be associated with significant improvement in GAD-related sleep disturbance across many controlled clinical trials, mediational analysis has suggested that a substantial portion of this effect could be the result of a direct effect of pregabalin. Thus, the objective of this study was to model the longitudinal latent effect of pregabalin or usual care (UC) therapies on changes in sleep in outpatients with GAD under routine clinical practice. Methods: Male and female GAD outpatients, aged 18 years or above, from a 6-month prospective noninterventional trial were analyzed. Direct and indirect effects of either pregabalin or UC changes in anxiety symptoms (assessed with Hamilton Anxiety Scale) and sleep disturbances (assessed with Medical Outcomes Study-Sleep Scale [MOS-S]) were estimated by a conditional latent curve model applying structural equation modeling. Results: A total of 1,546 pregabalin-naïve patients were analyzed, 984 receiving pregabalin and 562 UC. Both symptoms of anxiety and sleep disturbances were significantly improved in both groups, with higher mean (95% confidence interval) score reductions in subjects receiving pregabalin: -15.9 (-15.2; -16.6) vs -14.5 (-13.5; -15.5), P=0.027, in Hamilton Anxiety Scale; and -29.7 (-28.1; -31.3) vs -24.0 (-21.6; -26.4), P<0.001, in MOS-S. The conditional latent curve model showed that the pregabalin effect on sleep disturbances was significant (γ =-3.99, P<0.001), after discounting the effect on reduction in anxiety symptoms. A mediation model showed that 70% of the direct effect of pregabalin on sleep remained after discounting the mediated effect of anxiety improvement. Conclusion: A substantial proportion of the incremental improvements in anxiety-related sleep disturbances with pregabalin vs UC were explained by its direct effect, not mediated by improvements in anxiety symptoms. Keywords: latent curve analysis, pregabalin, usual care, generalized anxiety disorders, sleep disturbanceshttp://www.dovepress.com/modeling-the-longitudinal-latent-effect-of-pregabalin-on-self-reported-peer-reviewed-article-DDDT
spellingShingle Ruiz MA
Álvarez E
Carrasco JL
Olivares JM
Pérez M
Rejas J
Modeling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practice
Drug Design, Development and Therapy
title Modeling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practice
title_full Modeling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practice
title_fullStr Modeling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practice
title_full_unstemmed Modeling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practice
title_short Modeling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practice
title_sort modeling the longitudinal latent effect of pregabalin on self reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practice
url http://www.dovepress.com/modeling-the-longitudinal-latent-effect-of-pregabalin-on-self-reported-peer-reviewed-article-DDDT
work_keys_str_mv AT ruizma modelingthelongitudinallatenteffectofpregabalinonselfreportedchangesinsleepdisturbancesinoutpatientswithgeneralizedanxietydisordermanagedinroutineclinicalpractice
AT alvareze modelingthelongitudinallatenteffectofpregabalinonselfreportedchangesinsleepdisturbancesinoutpatientswithgeneralizedanxietydisordermanagedinroutineclinicalpractice
AT carrascojl modelingthelongitudinallatenteffectofpregabalinonselfreportedchangesinsleepdisturbancesinoutpatientswithgeneralizedanxietydisordermanagedinroutineclinicalpractice
AT olivaresjm modelingthelongitudinallatenteffectofpregabalinonselfreportedchangesinsleepdisturbancesinoutpatientswithgeneralizedanxietydisordermanagedinroutineclinicalpractice
AT perezm modelingthelongitudinallatenteffectofpregabalinonselfreportedchangesinsleepdisturbancesinoutpatientswithgeneralizedanxietydisordermanagedinroutineclinicalpractice
AT rejasj modelingthelongitudinallatenteffectofpregabalinonselfreportedchangesinsleepdisturbancesinoutpatientswithgeneralizedanxietydisordermanagedinroutineclinicalpractice